TWA
SPRB

TCI Wealth Advisors’s Spruce Biosciences SPRB Stock Holding History

TCI Wealth Advisors’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3
Closed -$553 – 2340
2023
Q1 		$553 Hold
3
– – ﹤0.01% 2202
2022
Q4 		$274 Hold
3
– – ﹤0.01% 2293
2022
Q3 		$0 Hold
3
– – ﹤0.01% 2640
2022
Q2 		$0 Hold
3
– – ﹤0.01% 2559
2022
Q1 		$1K Hold
3
– – ﹤0.01% 2172
2021
Q4 		$1K Buy
+3
New +$893 ﹤0.01% 2259

Other funds holding SPRB

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

TCI Wealth Advisors's SPRB Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Spruce Biosciences (SPRB) in Q2 2023, closing a stake of 3 shares — an estimated $553 sold.

TCI Wealth Advisors first reported a position in SPRB in Q4 2021 and held it in 6 quarters. The position peaked at $1K in Q1 2022. 38 funds tracked by Wall St. Rank hold SPRB as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Spruce Biosciences position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 3 Spruce Biosciences shares in Q2 2023, an estimated $553.
  • TCI Wealth Advisors first reported a position in Spruce Biosciences in Q4 2021 and held it in 6 quarters.
  • TCI Wealth Advisors's Spruce Biosciences position peaked at $1K in Q1 2022.
  • 38 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.